pet ct in melanoma clinicians guides to radionucl ances. As research advances, the development of melanoma-specific tracers and hybrid imaging techniques promises to further refine disease detection and guide personalized therapy. For clinicians, staying informed about these innovations and applying best practices will improve patient outcome May 15, 2026 Read more →
melanoma as: Anti-CTLA-4 agents (e.g., ipilimumab) Anti-PD-1 agents (e.g., pembrolizumab, nivolumab) Targeted Therapy: For BRAF-mutant melanomas, BRAF inhibitors (e.g., vemurafenib, dabrafenib) combined with MEK inhibitors (e.g., Jan 2, 2026 Read more →
histological diagnosis of nevi and melanoma rregular contours. Nuclear to cytoplasmic ratio: Increased, with prominent nucleoli. Mitotic activity: Increased, including atypical mitoses, especially in the dermal component. Pagetoid spread: Presence of atypical melanocytes above the basal layer, Apr 7, 2026 Read more →
